Compare Cognizant Technology Solutions Corp (CTSH) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cognizant Technology Solutions Corp vs Johnson & Johnson — how do they compare? Cognizant Technology Solutions Corp trades at $59.2 (market cap $27.03B), while Johnson & Johnson trades at $261.44 (market cap $618.09B). The key difference: Johnson & Johnson is far larger — about 22.9× Cognizant Technology Solutions Corp's market cap, and Cognizant Technology Solutions Corp pays the higher dividend (2.2%). Which is the better fit depends on your goals — on Pluang, investors hold Cognizant Technology Solutions Corp for 57 Days and Johnson & Johnson for 129 Days on average.
| CTSH | JNJ | |
|---|---|---|
Market Cap | $27.03B | $618.09B |
Volume | 9,883,888 | 6,050,983 |
Sector | Technology | Health |
52-Week High | $86.70 | $278.43 |
52-Week Low | $38.73 | $186.00 |
Typical Hold Time | 57 Days | 129 Days |
Enterprise Value | $28.08B | $646.37B |
Dividend Yield | 2.2% | 2.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cognizant Technology Solutions (CTSH) trades at $60.01, up 5.15% over 24 hours, reflecting strong momentum near its pivot point of $58. The stock shows bullish technical signals with moving averages supporting an uptrend. Fundamentally, CTSH maintains solid profitability with a 10.26% net margin and a modest P/E of 12.88. Recent earnings beats in Q4 2025 and Q1 2026 were offset by a Q2 2026 miss, with Q3 2026 results pending. Positive news includes AI-driven partnerships and employer awards, enhancing its growth narrative.
CTSH presents a balanced investment case with a consensus price target of $64.25 offering ~7% upside. Strengths include stable cash flow and undervaluation relative to peers, but risks involve IT spending pressures from AI disruption and competitive threats. Analyst sentiment is evenly split between Buy and Hold, indicating cautious optimism. The stock's outlook hinges on execution in AI services and sustaining margin discipline amid industry headwinds.
Johnson & Johnson (JNJ) trades at $256.48, down 0.76% on the day, with the stock showing mixed technical signals amid a bearish overall trend. The company maintains strong fundamentals with $94.19B in 2025 revenue, 21.48% net income margin, and consistent earnings beats in recent quarters. Recent analyst coverage shows 52.5% buy ratings with a $286.53 consensus price target, while technical indicators point to key support at $248 and resistance at $258.
JNJ presents a compelling long-term investment case with robust profitability, diversified healthcare portfolio, and dividend stability, though near-term headwinds include patent expirations and competitive pressures. The stock's current valuation at 29.75 P/E appears reasonable given strong cash flow generation and pipeline innovation, with upside potential to analyst targets if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cognizant Technology Solutions Corp
Cognizant is a global IT services provider, offering consulting and outsourcing services to some of the world's largest enterprises spanning the financial services, media and communications, healthcare, natural resources, and consumer products industries. Cognizant employs nearly 300,000 people globally, roughly 70% of whom are in India, although the company's headquarters are in Teaneck, New Jersey.
Read more on CTSH →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
